Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Abbott Laboratories
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Accounts=== For the fiscal year 2021, Abbott Laboratories reported earnings of US$7.071 billion, with an annual revenue of US$43.075 billion, which grew 24.5% on an organic basis versus the year prior. Abbott's year-end 2021 stock price was $140.74.<ref name="10-K 2021">{{cite web |url=https://www.sec.gov/ix?doc=/Archives/edgar/data/1800/000110465922025141/abt-20211231x10k.htm |title=US SEC: Form 10-K Abbott Laboratories |publisher=[[U.S. Securities and Exchange Commission]] |date=18 February 2022 |access-date=13 May 2022 |archive-date=20 April 2022 |archive-url=https://web.archive.org/web/20220420200250/https://www.sec.gov/ix?doc=/Archives/edgar/data/1800/000110465922025141/abt-20211231x10k.htm |url-status=live }}</ref><ref>{{Cite web|url=https://www.macrotrends.net/stocks/charts/ABT/abbott-laboratories/revenue|title=Abbott Laboratories Revenue 2006β2021 {{!}} ABT|website=macrotrends.net|access-date=1 November 2018|archive-date=2 November 2018|archive-url=https://web.archive.org/web/20181102014657/https://www.macrotrends.net/stocks/charts/ABT/abbott-laboratories/revenue|url-status=live}}</ref> {| class="wikitable float-left" style="text-align: right;" !Year !Revenue<br />in mil. US$ !Net income<br />in mil. US$ !Total assets<br />in mil. US$ !Price per share<br />in US$ !Employees |- |2005 |22,338 |3,372 |29,141 |17.37 | |- |2006 |22,476 |1,717 |36,178 |17.46 | |- |2007 |25,914 |3,606 |39,714 |21.34 | |- |2008 |29,528 |4,881 |42,419 |21.89 | |- |2009 |30,765 | 5,746 |52,582 |19.51 | |- |2010 |35,167 | 4,626 |60,574 |20.75 | |- |2011 |21,407 |4,728 |60,277 |21.26 | |- |2012 |19,050 |5,963 |67,235 |26.57 | |- |2013 |19,657 |2,576 |42,953 |31.90 |69,000 |- |2014 |20,247 |2,284 |41,207 |37.39 |77,000 |- |2015 |20,405 | 4,423 |41,247 |43.16 |74,000 |- |2016 |20,998 |1,400 |52,666 |38.65 |75,000 |- |2017 |27,390 |477 |76,250 |47.50 |99,000 |- |2018 |30,578 |2,368 |67,173 |69.50 |103,000 |- |2019 |31,904 |3,687 |67,887 |86.86 |107,000 |- |2020 |34,608 |4,495 |72,548 |109.49 |109,000 |- |2021 |43,075 |7,071 |75,196 |140.74 |113,000 |}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)